We’re now offically a Parkinson’s UK RIG. Our launch event was a huge success thanks to your engagement and involvement. Special thanks also go to Prof Monty Silverdale for telling us about his work on the ‘smell test’.
If you missed the event, or would like to watch again, just click the “Click here to watch the event” button, and enter the following passcode when you get to the Zoom page.
Dr Ellen Poliakoff (Body Eyes and Movement BEAM Lab, University of Manchester) is collaborating with researchers at the Royal Northern College of Music, Lucerne (Switzerland) and University of Exeter to explore how people with Parkinson’s use music to manage their movements and mood and movements. The survey should take approximately 30-45 minutes (or you can request to complete it via phone or video link). We will ask you to name pieces of music that you listen to for different reasons, so you might like to be close to your musical collection (iPod, CDs, records etc.), as well as about your music and dance experience. We will be recruiting until 28th June 2021. If you are interested, please follow this link
The World Parkinson Congress (WPC) is an international conference, held every 3 years, that provides a unique forum for researchers, clinicians and patients from across the world to meet and share knowledge about the latest developments in Parkinson’s research and treatment. The WPC’s goal is “to advance an all-encompassing approach to the treatment of Parkinson’s by bringing together the full spectrum of those who serve the Parkinson’s community and those who live with PD”.
My first WPC experience was Portland 2016, and as an early career researcher I was lucky to be awarded a travel grant to attend the congress. What first struck me was the number of people with Parkinson’s who had travelled to be there, and I immediately realised that WPC was going to be different to any of the other international conferences I’d been to. As much as I enjoyed hearing about the latest advances from world-leading experts, I also had the opportunity to gain insights directly from people with Parkinson’s, whether through discussing my research at the poster session or just chatting in the coffee breaks. This was a something I had not experienced before at a conference, and it reinforced the importance of our efforts as researchers to try and improve understanding of Parkinson’s and outcomes for those living with it.
I had met Colin, a person with Parkinson’s and research advocate, in the North West of England where we had begun to explore potential collaborative links, and was pleased to hear that he would also be going to the congress in Portland. It turned out Colin was already a WPC veteran, and when we met up again (in the Northwest USA this time) he introduced me to some of his contacts. Both Colin and I were also very fortunate to be able to attend the next WPC in 2019, in the beautiful city of Kyoto. By now we had discovered a shared interest in dance (mine from a scientific perspective; Colin’s as an aspiring tap dancer) and had worked on a research project together in Manchester. There is increasing interest among the Parkinson’s community in non-medical, widely available options such as dance (among others) to improve everyday life with the condition, and it was good to see this well represented in the 2019 program.
I would really encourage fellow researchers to attend the WPC for the opportunities it provides to make connections and gain insights from others working across different sections of the Parkinson’s community. However, WPC is more than an academic meeting. There is a great mix of talks, exhibitors, and creative projects to immerse yourself in, and the atmosphere is truly inspiring.
I’m looking forward to the next WPC in Barcelona in June 2022, which I hope will see a greater presence from across the Parkinson’s community (scientists, clinicians and patients) in Europe. Starting in May 2021, there will also now be a virtual congress in the years between the triennial event, providing an opportunity to keep up to date with the latest developments.
Colin’s experience of the World Parkinson’s Congress
What do the following cities have in common: Washington, Glasgow, Montreal, Portland and Kyoto?
Answer: they have all hosted meetings of the World Parkinson Congress. The Congress meets every three years, attracting delegates from all over the world. It brings together the very best researchers, clinicians, healthcare professionals and therapists. However, it is not simply a conference for those with scientific or professional interest. It is equally focused on the involvement and engagement of people with Parkinson’s and their carers, plus the voluntary organisations that support people who are living with the condition on a daily basis.
I was diagnosed with Parkinson’s in 2001 at the age of 54 and within a year, I had taken early retirement. I knew that Parkinson’s was progressive and I had seen others with the condition go into a rapid decline. I therefore waited with some trepidation to see how it was going to affect me. Meanwhile, having no paid work to do, I began to get involved in Parkinson’s UK as a volunteer, at first in my local Branch and eventually as a Trustee. This is when I first came across the WPC.
When the second World Congress took place in Glasgow, Parkinson’s UK were involved as the main host organisation. As a Trustee, therefore, I found myself in Glasgow as part of the Parkinson’s UK’s meet and greet team. I had been to many large conferences in my working life, but the WPC was a revelation. What made it unique was its accessibility to anyone with an interest in Parkinson’s. For example, a person with Parkinson’s could listen to an account of the latest developments in brain surgery in one lecture room, and then move to the room next door for a class teaching yoga for Parkinson’s.
The range of issues covered in the 5 days was mind boggling. Everyone I spoke to at, or after, the conference felt that the quality of the engagement between the participants was really valuable, and really stimulating. I could understand why people were prepared to travel from every corner of the globe to be part of it, including my contacts from Parkinson’s New South Wales in Australia who I had met previously during a personal trip. But for the Congress, that link would have simply remained a pleasant memory, whereas it developed into a more enduring relationship.
What’s in it for me?
There are probably as many reasons for people to attend the Congress as there are delegates. Here are just some of the reasons that might be relevant in coming to a decision. Next year the location of Barcelona may put attendance more within reach for many whose home base is in Europe.
Interaction with people with Parkinson’s, which sets a context for the researcher’s task and provides a link between the research challenge and its potential outputs.
Cutting edge research – to update one’s knowledge of the latest developments from some of the world’s leading experts.
Presenting results – an opportunity to raise the profile of completed research projects and their conclusions in a poster display hall visited by hundreds of delegates.
Sharing thinking – learning about what other research teams are doing and how their projects may relate to yours.
The clinician and other health care professionals:
Interaction with researchers and identifying priorities for research.
Engagement with patients to explain and gain support for clinical trials.
To learn about the latest medical, surgical and other treatment options.
The person with Parkinson’s:
Knowledge and understanding to enable you to maximise the opportunities and resources available that can support you to live well independently. This knowledge and understanding can be acquired not only through engagement with the professionals but also from other people with Parkinson’s.
Confidence is a critical attribute in managing the condition and making treatment choices. This can be enhanced through engagement with others. Patients should not feel they have to face Parkinson’s alone.
Would I go again?
Like a shot! I enjoyed the Glasgow event so much that I made myself a promise to attend every subsequent Congress that I could. Since then my wife and I have managed to adjust our holiday schedule to take in the meetings in Montreal, Portland and Kyoto. And what’s not to like about Barcelona in June…?
You can read more about WPC 2022 here, and register for the virtual congress (17-21 May 2021) here.
2:00 Seminar style talk from Professor Monty Silverdale
Title: Diagnosing the Scent of Parkinson’s with Mass Spectrometry and Joy
The chance of developing a cure for Parkinson’s disease will be massively improved if we are able to diagnose the condition at an earlier stage. Joy Milne, a ‘super-smeller’ from Edinburgh, noticed an unusual musky smell on her husband Les, 12 years before he developed Parkinson’s disease. This chance finding has enabled us to develop a test for Parkinson’s disease using a simple skin swab. Our test may be able to diagnose the condition more than 10 years before it is currently possible. This will speed up the development of a cure.
Professor Silverdale will tell the amazing story of Joy and how her nose may lead to a cure for Parkinson’s disease.
World Parkinson’s Day (11th April) kicks off Parkinson’s awareness week, an annual opportunity to raise funds and increase awareness. To mark the occasion, the Parkinson’s UK’s North West RIG is publishing a series of blogs throughtout the week.
First up, let’s address a subject that people with Parkinson’s are often all too aware of: constipation.
Diagnosing Parkinson’s is incredibly difficult in the early stages. Symptoms that emerge before movements are affected offer the opportunity to reach an accurate diagnosis sooner. Importantly, this also means faster initiation of the treatments that will make people’s lives easier.
As yet, there are no treatments that prevent or delay Parkinson’s. But, trials of new drugs are underway. However, even the most promising drug will fail if it’s not tested on the people it’s designed for (there is little point evaluating a disease-modifying treatment in people who have no disease to modify). So, while uncomfortable (on several levels), talking about constipation may be critical for the future of Parkinson’s medication.
All that said, there are many reasons a person may be experiencing bathroom-related troubles, most of which are unrelated to Parkinson’s. This brings us to the second reason why we’re talking about constipation: how to identify the people with constipation who are in the early stages of Parkinson’s.
In a recent development, a team of researchers from Israel, Germany and Canada have uncovered the link between the very earliest stages of Parkinson’s and constipation. The team induced Parkinson’s-like pathology in the dorsal motor nucleus of the vagus in rodents. In humans, this is one of the earliest regions to develop Parkinson’s pathology. It also happens to connect with the gastrointestinal tract (the organs by which food and liquids make their way from one end of us, to the other, see image below).
After Parkinson’s pathology became established in the rodent vagus, its connections to the gastrointestinal tract became less active. Through a series of experiments, the authors confirmed that this drop in activity caused the rodents to pass bigger and less frequent droppings. Sound familiar?
This work offers a new opportunity to use constipation as a predictor of Parkinson’s more accurately. Developing tools to detect changes in the vagus in people who are also constipated would help us predict who will develop Parkinson’s, and who may just need to hydrate more.
At Manchester Metropolitan we are using artificial intelligence analysis of medical images to measure the health of the vagus for the first time. We hope this will help us to identify people at risk of Parkinson’s long before they experience any motor symptoms.
In the meantime, for those of you who may be struggling with constipation, one of our members has some words of wisdom:
“The big P has several manifestations. One is certain muscles not responding to instructions from headquarters. As in my case, lips not being firm enough to stop drooling for one thing. At the other end of my languid body I have a more pressing problem. My rear end exit muscles have retrograded from automatic back to manual. Constipation is the word! The action required message just does not arrive and there is a pile up, luckily the police don’t turn out. It seems nothing can be done for the mechanism except the usual medication, but help is there in terms of softening the issue, if you get my meaning. A dose of CosmoCol each morning allows an easier passage, if not to India at least to somewhere useful nearby.”
It was wonderful to see so many of you at our first open meeting via Zoom. This is just a quick update re: discussions and how we’ve followed-up.
After a few introductions, we discussed whether the group needed a social media presence. There was a mixed response (some prefer Facebook, some Twitter, some neither!). We agreed that Facebook was most used, and Twitter has its uses. But, we’ll also make sure that important information is communicated here on the website and via email.
Our Facebook and Twitter groups are now ready to use, and you can join via the buttons on the top right of this page.
2. The main discussion was around the format of the online event planned for Friday May 14th. The group are really keen for the event to happen, and think there will be a lot of interest in attending across the region and beyond.
However, in my enthusiasm to showcase some of the brilliant research going on in universities and NHS trusts across the North West, I had planned a too-full schedule. Instead, many in the group felt the launch event should focus on one or two speakers, with plenty of time for Q&A. This makes a lot of sense to me (I’m now well accustomed to screen fatigue), and we’ve re-thought the event along those lines.
I will send out a poster to advertise the event when we’ve finalised the speakers.
3. We had a few offers from members who would like to contribute to the group by writing blogs, speaking about their experiences at meetings, and even running online dance taster sessions! We’re really grateful for all these responses, and please do feel free to get in touch if you’d like to get involved too.
4. Finally, it was stressed that our group should focus on making sure there are opportunities for people with Parkinson’s to be involved in research from the earliest stages. We’re very lucky to have some experts on Patient and Public Involvement among us, and we were happy to hear they’re keen to share their ideas at future meetings.
As always, please feel free to contact me: firstname.lastname@example.org if you have any thoughts